glp 1 kidney disease Frontiers New Guideline Puts Some at

A 2022 meta-analysis of 37 RCTs involving 3,048 patients, published in Frontiers in Pharmacology , found that berberine significantly reduced fasting plasma glucose by an average of 0.82 mmol/L and HbA1c by 0.63% without significantly increasing hypoglycemia risk

Pediatric GHD patients with coexisting ACTH deficiency should have their glucocorticoid replacement dose carefully adjusted to avoid an inhibitory effect on growth

Metabolism addiction in pancreatic cancer

15 Both dysbiosis and impaired gut integrity have been strongly associated with the development of overweight, obesity and metabolic syndrome, and should be a key focus of therapeutic protocols either independent of or alongside GLP-1 agonist therapy in supporting weight management